Quarterly report pursuant to Section 13 or 15(d)

Equity based compensation - Summary of stock options (Details)

v3.21.2
Equity based compensation - Summary of stock options (Details)
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Reload Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of options, Granted | shares 4,592,319
Number of options, Ending of period | shares 4,592,319
Weighted average exercise price, granted | $ / shares $ 23.50
Weighted Average Grant Date Fair Value, End of period | $ / shares $ 23.50
Staking Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of options, Granted | shares 66,667
Number of options, Ending of period | shares 66,667
Weighted average exercise price, granted | $ / shares $ 23.50
Weighted Average Grant Date Fair Value, End of period | $ / shares $ 23.50
Class C Incentive Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares 3,911,490
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 3,911,490
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares $ 23.50
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 23.50
Class C Incentive Unit Staking Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares 2,116,667
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 2,116,667
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares $ 23.50
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 23.50